Innate immune signaling drives late cardiac toxicity following DNA-damaging cancer therapies
暂无分享,去创建一个
Melody Di Bona | N. Socci | A. Schmitt | Jennifer E Liu | S. Bakhoum | L. Ramanathan | R. Steingart | K. Oeffinger | A. Piersigilli | C. Dang | Jun Li | A. Yu | A. Shamseddine | Valery Chavez | Suchit Patel | A. Chan | M. Adnan
[1] Chaoyong He,et al. Activation of STING Pathway Contributed to Cisplatin-Induced Cardiac Dysfunction via Promoting the Activation of TNF-α-AP-1 Signal Pathway , 2021, Frontiers in Pharmacology.
[2] S. Feigenberg,et al. A Novel Mouse Model of Radiation-Induced Cardiac Injury Reveals Biological and Radiological Biomarkers of Cardiac Dysfunction with Potential Clinical Relevance , 2021, Clinical Cancer Research.
[3] O. Elemento,et al. Metastasis and immune evasion from extracellular cGAMP hydrolysis. , 2020, Cancer discovery.
[4] Zhijian J. Chen,et al. Structures and Mechanisms in the cGAS-STING Innate Immunity Pathway. , 2020, Immunity.
[5] J. Zamorano,et al. Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations. , 2020, Annals of oncology : official journal of the European Society for Medical Oncology.
[6] R. Zhou,et al. DAMP-sensing receptors in sterile inflammation and inflammatory diseases , 2019, Nature Reviews Immunology.
[7] K. Fitzgerald,et al. DNA sensing by the cGAS–STING pathway in health and disease , 2019, Nature Reviews Genetics.
[8] H. Rui,et al. Mapping genetic modifiers of radiation-induced cardiotoxicity to rat chromosome 3. , 2019, American journal of physiology. Heart and circulatory physiology.
[9] V. Petrilli,et al. [Cytosolic DNA sensing by the cGAS-STING pathway in cancer]. , 2019, Medecine sciences : M/S.
[10] Katherine Lee Chuy,et al. Cardiotoxicity of Contemporary Breast Cancer Treatments , 2019, Current Treatment Options in Oncology.
[11] D. de Ruysscher,et al. Radiotherapy toxicity , 2019, Nature Reviews Disease Primers.
[12] Radiotherapy toxicity , 2019, Nature Reviews Disease Primers.
[13] Christoph D. Rau,et al. Genetic Regulation of Fibroblast Activation and Proliferation in Cardiac Fibrosis , 2018, Circulation.
[14] B. Li,et al. Conventional Dendritic Cells Impair Recovery after Myocardial Infarction , 2018, The Journal of Immunology.
[15] G. Turcatti,et al. Targeting STING with covalent small-molecule inhibitors , 2018, Nature.
[16] Herman I. May,et al. Cytosolic DNA Sensing Promotes Macrophage Transformation and Governs Myocardial Ischemic Injury , 2018, Circulation.
[17] Andrej J. Savol,et al. IRF3 and Type I Interferons Fuel a Fatal Response to Myocardial Infarction , 2017, Nature Medicine.
[18] A. De Angelis,et al. Oxidative Stress and Cellular Response to Doxorubicin: A Common Factor in the Complex Milieu of Anthracycline Cardiotoxicity , 2017, Oxidative medicine and cellular longevity.
[19] Dennis E Discher,et al. Mitotic progression following DNA damage enables pattern recognition within micronuclei , 2017, Nature.
[20] Yusuke Nakamura,et al. The Transcriptional Landscape of p53 Signalling Pathway , 2017, EBioMedicine.
[21] V. Hornung,et al. Recognition of Endogenous Nucleic Acids by the Innate Immune System. , 2016, Immunity.
[22] J. Edwards,et al. Doxorubicin induced heart failure: Phenotype and molecular mechanisms , 2015, International journal of cardiology. Heart & vasculature.
[23] D. Tsiantoulas,et al. B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction , 2013, Nature Medicine.
[24] P. Hall,et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. , 2013, The New England journal of medicine.
[25] E. Yeh,et al. Identification of the molecular basis of doxorubicin-induced cardiotoxicity , 2012, Nature Medicine.
[26] P. Graves,et al. A mouse model of radiation-induced cardiomyopathy. , 2012, International journal of cardiology.
[27] R Peto,et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials , 2011, The Lancet.
[28] Grace Y Chen,et al. Sterile inflammation: sensing and reacting to damage , 2010, Nature Reviews Immunology.
[29] A. Hart,et al. Late cardiotoxicity after treatment for Hodgkin lymphoma. , 2007, Blood.
[30] D. Greenfield,et al. High incidence of late effects found in Hodgkin's lymphoma survivors, following recall for breast cancer screening , 2006, British Journal of Cancer.
[31] D. Rothenbacher,et al. Differential Expression of Chemokines, Risk of Stable Coronary Heart Disease, and Correlation with Established Cardiovascular Risk Markers , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[32] H. Bartelink,et al. Long-term cause-specific mortality of patients treated for Hodgkin's disease. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[33] S. Swain,et al. Congestive heart failure in patients treated with doxorubicin , 2003, Cancer.
[34] R. Greil,et al. Low-dose radiation is sufficient for the noninvolved extended-field treatment in favorable early-stage Hodgkin's disease: long-term results of a randomized trial of radiotherapy alone. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[35] J. R. Stewart,et al. Radiation injury to the heart. , 1995, International journal of radiation oncology, biology, physics.
[36] P. Rubin,et al. Radiation effects on left ventricular function and myocardial perfusion in long term survivors of Hodgkin's disease. , 1990, International journal of radiation oncology, biology, physics.
[37] E. Henderson,et al. Heart size and function after radiation therapy to the mediastinum in patients with Hodgkin's disease. , 1983, Cancer treatment reports.
[38] J. Herman,et al. Detection of radiation cardiomyopathy by gated radionuclide angiography. , 1983, The American journal of medicine.
[39] B. Culliton,et al. Low-dose radiation. , 1979, British medical journal.
[40] K. Rosenzweig,et al. Definitive radiation therapy in locally advanced non-small cell lung cancer: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based clinical practice guideline. , 2015, Practical radiation oncology.
[41] J. Pincemail,et al. [Oxidative stress]. , 2007, Revue medicale de Liege.
[42] T. Landberg,et al. Late cardiac effects after mantle radiotherapy in patients with Hodgkin's disease. , 1990, Annals of oncology : official journal of the European Society for Medical Oncology.